FDA - PDS Symposium IX Rare Cancer Registries

Description

Rare cancer registries hold potential to solve some of the most difficult challenges to advancing treatment of these rare cancers, which account for more than 20% of the cancers reported worldwide.

We are honored and excited to welcome keynote speaker Dr. David Fajgenbaum, a groundbreaking physician-scientist, disease hunter, speaker, and author of the national bestselling memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action.  He has also developed and led an innovative approach to research through the Castleman Disease Collaborative Network (CDCN).

The symposium will bring together multiple stakeholders representing all sides of this challenge: Practice in the clinic, Pharmaceutical research, Policy and regulatory science, and Patient advocacy to brainstorm the operational dynamics between the groups. 

We invite you to participate by sharing your questions which you can do at registration and during the Q&A sessions.  In addition, the first 75 registrants who attend the session are able to receive a complimentary copy of Dr. Fajgenbaum's book.  Register early!

Let's use this symposium to drive improvements in patient care together.  

For more information about this event and to view the full agenda, visit our website.